Literature DB >> 20037456

[A case of postoperative liver metastasis of esophageal cancer remains in progression free after successfully resected].

Yutaka Tokairin1, Youichi Kumagai, Shigeru Yamazaki.   

Abstract

A 59-year-old man admitted for upper gastrointestinal endoscopy of the health examination in the middle of October 2005 was diagnosed with advanced lower esophageal cancer. After a precise examination, he received a subtotal esophagectomy followed by three-field lymphadenectomy in the beginning of November 2005. The histopathological diagnosis was well differentiated squamous cell carcinoma (pT3, ie (+), ly2, v2, pIM0, pN3, pStage III). After two courses of systemic chemotherapy so called FP therapy, solitary liver metastasis in S8 area was detected in May 2007. He received additional two courses of FP chemotherapy, but the CT scan revealed that the lesion was progress disease (PD) in December 2007. It seemed to be difficult to reduce the tumor progression by systemic chemotherapy, so S8 semi-segmental lobectomy was performed. After the operation, the patient received the combination chemotherapy with docetaxel and nedaplatin once a week on day 1 for 4 weeks in five courses, but the CT scan revealed the appearance of the recurrence of residual liver and abdominal lymphnodes in January 2009. So a right hepatic lobectomy and lymphadenectomy were performed. The patient also received chemoradiotherapy after the operation, no recurrence of the liver and lymphnodes metastases has been shown. Surgical resection was sometimes seemed to be effective for treating liver metastasis of esophageal cancer, thus indication of operation need to be discussed for accumulation of many liver metastasis of esophageal cancer.

Entities:  

Mesh:

Year:  2009        PMID: 20037456

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  4 in total

1.  Case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case.

Authors:  Daisuke Iitaka; Atsushi Shiozaki; Hitoshi Fujiwara; Daisuke Ichikawa; Kazuma Okamoto; Shuhei Komatsu; Yasutoshi Murayama; Hisashi Ikoma; Yoshiaki Kuriu; Masayoshi Nakanishi; Toshiya Ochiai; Yukihito Kokuba; Teruhisa Sonoyama; Eigo Otsuji
Journal:  Surg Today       Date:  2012-07-01       Impact factor: 2.549

2.  Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer.

Authors:  Jing Xu; Donghui Lu; Li Zhang; Jian Li; Guoping Sun
Journal:  Cancer Med       Date:  2019-10-14       Impact factor: 4.452

3.  A machine learning model predicting candidates for surgical treatment modality in patients with distant metastatic esophageal adenocarcinoma: A propensity score-matched analysis.

Authors:  Fang Liao; Shuangbin Yu; Ying Zhou; Benying Feng
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

Review 4.  The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature.

Authors:  Dimitrios Schizas; Ioannis I Lazaridis; Demetrios Moris; Aikaterini Mastoraki; Lazaros-Dimitrios Lazaridis; Diamantis I Tsilimigras; Nikolaos Charalampakis; Theodore Liakakos
Journal:  World J Surg Oncol       Date:  2018-03-14       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.